Author

Antal Zemplenyi

Observed names: Antal Zemplényi, Zemplényi, Antal

Institutions: Syreon Research Institute (Hungary), University of Colorado Anschutz, University of Pecs

Observed institutions: University of South Bohemia in České Budějovice, Syreon Research Institute (Hungary), University of Colorado Anschutz, University of Pecs

ORCID: 0000-0002-0177-0264

Observed ORCID: 0000-0002-0177-0264

OpenAlex ID: A5132898032

The effectiveness and value of B-cell–directed therapies for the treatment of immunoglobulin A nephropathy: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

2026 · Avery McKenna, Jason H. Wasfy, et al. · Journal of Managed Care & Specialty Pharmacy · 1

Effect of telemedicine-delivered lifestyle interventions in older adults during the COVID-19 pandemic: a nationwide two-arm randomized trial (PROACTIVE-19)

2026 · Szilárd Váncsa, Anett Nagy-Szakolczai, et al. · GeroScience

Dissertation Topic Selection Priorities Among Pharmaceutical Outcomes Research Students and Alumni

2026 · Mouna Dardouri, Antal Zemplenyi, et al. · American Journal of Pharmaceutical Education

From general-purpose models to purpose-built artificial intelligence systems for health economic modeling

2026 · Attila Imre, Bertalan Nemeth, et al. · Expert Review of Pharmacoeconomics & Outcomes Research

Ee305 Generative Ai in Health Economic Modelling: a Targeted Review of Emerging Applications and Methodological Gaps

2026 · Attila Imre, Bertalan Németh, et al. · Value in Health

Works count: 6

Citation count: 1

H-index: 1

I10-index: